The present invention is concerned with novel spiro-piperidine derivatives as V1a receptor antagonists, their manufacture, pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are useful in the prevention and/or treatment of anxiety and depressive disorders and other diseases.
In particular, the present invention is concerned with compounds of the general formula (I)
wherein R
1
to R
5
, R
5
′, X, Y and A are as defined in the specification.
本发明涉及作为V1a受体拮抗剂的新颖螺环
哌啶衍
生物,其制备方法,含有它们的药物组合物以及它们作为药物的用途。本发明的活性化合物在预防和/或治疗焦虑和抑郁症等疾病方面是有用的。具体而言,本发明涉及一般式(I)的化合物,其中R1至R5,R5',X,Y和A如规范中所定义。